Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium

Journal of Virology

Volumn 87, Issue 8, 2013, Pages 4237-4251

  Beaulieu, Alexandre ^a   Gravel, Émilie ^a   Cloutier, Alexandre ^a   Marois, Isabelle ^a   Colombo, Éloïc ^a   Désilets, Antoine ^a   Verreault, Catherine ^a   Leduc, Richard ^a   Marsault, Éric ^a   Richter, Martin V ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; MATRIPTASE;

2009 H1N1 INFLUENZA; ARTICLE; CELL SURFACE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME LOCALIZATION; EPITHELIUM CELL; EXTRACELLULAR SPACE; GENE SILENCING; HUMAN; HUMAN CELL; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS VIRULENCE;

ENDOSOMES; EPITHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; INFLUENZA A VIRUS; MICROSCOPY, CONFOCAL; RESPIRATORY MUCOSA; SERINE ENDOPEPTIDASES; VIRUS REPLICATION;

ORTHOMYXOVIRIDAE;

EID: 84875781290     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03005-12     Document Type: Article

References (60)

1. Stohr K. 2003. Preventing and treating influenza. BMJ 326:1223-1224.
2. Park AW, Glass K. 2007. Dynamic patterns of avian and human influenza in East and Southeast Asia. Lancet Infect. Dis. 7:543-548.
3. Cheung TK, Poon LL. 2007. Biology of influenza a virus. Ann. N. Y. Acad. Sci. 1102:1-25.
4. Both GW, Sleigh MJ, Cox NJ, Kendal AP. 1983. Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J. Virol. 48:52-60.
5. Treanor J. 2004. Influenza vaccine-outmaneuvering antigenic shift and drift. N. Engl. J. Med. 350:218-220.
6. Cox NJ, Subbarao K. 2000. Global epidemiology of influenza: past and present. Annu. Rev. Med. 51:407-421.
7. Koelle K, Cobey S, Grenfell B, Pascual M. 2006. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314:1898-1903.
8. Plotkin JB, Dushoff J, Levin SA. 2002. Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc. Natl. Acad. Sci. U. S. A. 99:6263-6268.
9. De Clercq E. 2006. Antiviral agents active against influenza A viruses. Nat. Rev. Drug Discov. 5:1015-1025.
10. Hayden FG, Hay AJ. 1992. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr. Top. Microbiol. Immunol. 176:119-130.
11. Garten W, Klenk HD. 2008. Cleavage activation of the influenza virus hemagglutinin and its role in pathogenesis. Karger, Basel, Switzerland.
12. Klenk HD, Garten W. 1994. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 2:39-43.
13. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569.
14. Steinhauer DA. 1999. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258:1-20.
15. Basak A, Zhong M, Munzer JS, Chretien M, Seidah NG. 2001. Implication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: a comparative analysis with fluorogenic peptides. Biochem. J. 353: 537-545.
16. Horimoto T, Nakayama K, Smeekens SP, Kawaoka Y. 1994. Proproteinprocessing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. J. Virol. 68:6074-6078.
17. Stieneke-Grober A, Vey M, Angliker H, Shaw E, Thomas G, Roberts C, Klenk HD, Garten W. 1992. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11:2407-2414.
18. Zambon MC. 2001. The pathogenesis of influenza in humans. Rev. Med. Virol. 11:227-241.
19. Bottcher E, Matrosovich T, Beyerle M, Klenk HD, Garten W, Matrosovich M. 2006. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol. 80: 9896-9898.
20. Bertram S, Glowacka I, Blazejewska P, Soilleux E, Allen P, Danisch S, Steffen I, Choi SY, Park Y, Schneider H, Schughart K, Pohlmann S. 2010. TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. J. Virol. 84:10016-10025.
21. Bottcher E, Freuer C, Steinmetzer T, Klenk HD, Garten W. 2009. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Vaccine 27:6324-6329.
22. Bottcher-Friebertshauser E, Freuer C, Sielaff F, Schmidt S, Eickmann M, Uhlendorff J, Steinmetzer T, Klenk HD, Garten W. 2010. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J. Virol. 84:5605-5614.
23. Hamilton BS, Gludish DW, Whittaker GR. 2012. Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities. J. Virol. 86:10579-10586.
24. Bottcher-Friebertshauser E, Stein DA, Klenk HD, Garten W. 2011. Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin- activating protease TMPRSS2. J. Virol. 85:1554-1562.
25. Glowacka I, Bertram S, Muller MA, Allen P, Soilleux E, Pfefferle S, Steffen I, Tsegaye TS, He Y, Gnirss K, Niemeyer D, Schneider H, Drosten C, Pohlmann S. 2011. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J. Virol. 85:4122-4134.
26. Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F. 2010. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J. Virol. 84:12658-12664.
27. Shirato K, Matsuyama S, Ujike M, Taguchi F. 2011. Role of proteases in the release of porcine epidemic diarrhea virus from infected cells. J. Virol. 85:7872-7880.
28. Shirogane Y, Takeda M, Iwasaki M, Ishiguro N, Takeuchi H, Nakatsu Y, Tahara M, Kikuta H, Yanagi Y. 2008. Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J. Virol. 82:8942-8946. 29. Choi SY, Bertram S, Glowacka I, Park YW, Pohlmann S. 2009. Type II transmembrane serine proteases in cancer and viral infections. Trends Mol. Med. 15:303-312.
29. Choi SY, Bertram S, Glowacka I, Park YW, Pohlmann S. 2009. Type II transmembrane serine proteases in cancer and viral infections. Trends Mol. Med. 15:303-312.
30. Szabo R, Bugge TH. 2008. Type II transmembrane serine proteases in development and disease. Int. J. Biochem. Cell Biol. 40:1297-1316.
31. List K, Kosa P, Szabo R, Bey AL, Wang CB, Molinolo A, Bugge TH. 2009. Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway. Am. J. Pathol. 175:1453-1463.
32. Oberst MD, Singh B, Ozdemirli M, Dickson RB, Johnson MD, Lin CY. 2003. Characterization of matriptase expression in normal human tissues. J. Histochem. Cytochem. 51:1017-1025.
33. Wang JK, Lee MS, Tseng IC, Chou FP, Chen YW, Fulton A, Lee HS, Chen CJ, Johnson MD, Lin CY. 2009. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. Am. J. Physiol. Cell Physiol. 297:C459-C470.
34. Lin CY, Tseng IC, Chou FP, Su SF, Chen YW, Johnson MD, Dickson RB. 2008. Zymogen activation, inhibition, and ectodomain shedding of matriptase. Front. Biosci. 13:621-635.
35. Cloutier A, Marois I, Cloutier D, Verreault C, Cantin AM, Richter MV. 2012. The prostanoid 15-deoxy-δ12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection. J. Infect. Dis. 205:621-630.
36. Cottey R, Rowe CA, Bender BS. 2001. Influenza virus. Curr. Protoc. Immunol. Chapter 19, unit 19.11. doi:10.1002/0471142735.im1911s42.
37. Marois I, Cloutier A, Garneau E, Richter MV. 2012. Initial infectious dose dictates the innate, adaptive, and memory responses to influenza in the respiratory tract. J. Leukoc. Biol. 92:107-121.
38. Desilets A, Longpre JM, Beaulieu ME, Leduc R. 2006. Inhibition of human matriptase by eglin c variants. FEBS Lett. 580:2227-2232.
39. Beliveau F, Desilets A, Leduc R. 2009. Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides. FEBS J. 276:2213-2226.
40. Manders EMM, Verbeek FJ, Aten JA. 1993. Measurement of co-localization of objects in dual-colour confocal images. J. Microsc. 169:375-382.
41. Colombo E, Désilets A, Duchêne D, Chagnon F, Najmanovich R, Leduc R, Marsault E. 2012. Design and synthesis of potent, selective inhibitors of matriptase. ACS Med. Chem. Lett. 3:530-534.
42. Steinmetzer T, Dönnecke D, Korsonewski M, Neuwirth C, Steinmetzer P, Schulze A, Saupe SM, Schweinitz A. 2009. Modification of the N-terminal sulfonyl residue in 3-amidinophenylalanine-based matriptase inhibitors. Bioorg. Med. Chem. Lett. 19:67-73.
43. Yoshimura A, Ohnishi S. 1984. Uncoating of influenza virus in endosomes. J. Virol. 51:497-504.
44. Steinhauer DA, Martin J, Lin YP, Wharton SA, Oldstone MB, Skehel JJ, Wiley DC. 1996. Studies using double mutants of the conformational transitions in influenza hemagglutinin required for its membrane fusion activity. Proc. Natl. Acad. Sci. U. S. A. 93:12873-12878.
45. Roy AM, Parker JS, Parrish CR, Whittaker GR. 2000. Early stages of influenza virus entry into Mv-1 lung cells: involvement of dynamin. Virology 267:17-28.
46. Guinea R, Carrasco L. 1995. Requirement for vacuolar proton- ATPase activity during entry of influenza virus into cells. J. Virol. 69:2306-2312.
47. Bullough PA, Hughson FM, Skehel JJ, Wiley DC. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43.
48. Sollner TH. 2004. Intracellular and viral membrane fusion: a uniting mechanism. Curr. Opin. Cell Biol. 16:429-435.
49. Chen Y, Shiota M, Ohuchi M, Towatari T, Tashiro J, Murakami M, Yano M, Yang B, Kido H. 2000. Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Purification and characterization. Eur. J. Biochem. 267:3189-3197.
50. Kido H, Okumura Y, Takahashi E, Pan HY, Wang S, Yao D, Yao M, Chida J, Yano M. 2012. Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure. Biochim. Biophys. Acta 1824:186-194.
51. Kido H, Yokogoshi Y, Sakai K, Tashiro M, Kishino Y, Fukutomi A, Katunuma N. 1992. Isolation and characterization of a novel trypsinlike protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J. Biol. Chem. 267:13573-13579.
52. Bertram S, Heurich A, Lavender H, Gierer S, Danisch S, Perin P, Lucas JM, Nelson PS, Pohlmann S, Soilleux EJ. 2012. Influenza and SARScoronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One 7:e35876. doi:10.1371/journal.pone.0035876.
53. Chaipan C, Kobasa D, Bertram S, Glowacka I, Steffen I, Tsegaye TS, Takeda M, Bugge TH, Kim S, Park Y, Marzi A, Pohlmann S. 2009. Proteolytic activation of the 1918 influenza virus hemagglutinin. J. Virol. 83:3200-3211.
54. Bugge TH, List K, Szabo R. 2007. Matriptase-dependent cell surface proteolysis in epithelial development and pathogenesis. Front. Biosci. 12: 5060-5070.
55. Bugge TH, Antalis TM, Wu Q. 2009. Type II transmembrane serine proteases. J. Biol. Chem. 284:23177-23181.
56. Domoto T, Takino T, Guo L, Sato H. 2012. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase. Cancer Sci. 103:448-454.
57. Chen J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, Wiley DC. 1998. Structure of the hemagglutinin precursor cleavage site, a determinant ofinfluenza pathogenicity and the origin of the labile conformation. Cell 95:409-417.
58. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, Wilson IA. 2004. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303:1866-1870.
59. Baron J, Tarnow C, Mayoli-Nussle D, Schilling E, Meyer D, Hammami M, Schwalm F, Steinmetzer T, Guan Y, Garten W, Klenk HD, Bottcher- Friebertshauser E. 28 November 2012. Matriptase, HAT and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses. J. Virol. doi:10.1128/JVI.02320-12.
60. Assis DN, Lim JK. 2012. New pharmacotherapy for hepatitis C. Clin. Pharmacol. Ther. 92:294-305.